<DOC>
	<DOCNO>NCT01726335</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety tolerance long-acting risperidone switch oral antipsychotic participant schizophrenia ( psychiatric disorder symptom emotional instability , detachment reality , often delusion hallucination , withdrawal self ) .</brief_summary>
	<brief_title>Switching From Oral Antipsychotics Long-Acting Risperidone Participants With Schizophrenia</brief_title>
	<detailed_description>This open-label ( people know identity intervention ) , multi-centric ( conducted one center ) non-comparative study long-acting risperidone participant schizophrenia previous history ( last 12 month ) bad adherence oral antipsychotic treatment first second generation . The duration study 24 week include follow visit : Screening , Baseline , Week 2 , 4 , 8 , 12 , 16 , 20 , 24 , 38 50 ( End visit early withdrawal ) . All eligible participant ( risperidone intolerance test screening ) receive dose 25 milligram risperidone every two week intramuscular injection ( injection substance muscle ) . Efficacy safety participant primarily evaluate Positive Negative Syndromes Scale Extrapyramidal Symptom Rating Scale , respectively . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Have schizophrenia diagnosis Diagnostic Statistical Manual Mental Disorders , fourth edition ( DSMIV ) Be treatment oral antipsychotic first second generation , minimum time 12 month Previous history bad adhesion oral antipsychotic treatment last 12 month Total Positive Negative Syndrome Scale score less equal 90 , conceptual disorganization , hallucinatory behavior , suspicion usual content think must less equal 4 Be pregnant show negative pregnancy serum test Contraindication know hypersensitivity risperidone Previous history unsatisfactory response risperidone Previous history refractivity second generation antipsychotic Use antipsychotic intramuscular deposit last 12 month Other mental disturbance DSMIV axis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Risperidone</keyword>
	<keyword>Risperdal consta</keyword>
</DOC>